Strategies for optimizing medication adherence in schizophrenia. Debbi A. Morrissette, Andrew J. Cutler.CNS Spectrums, volume 17, issue 01, pp. 31-41. VIEW RESEARCH PUBLICATION.

Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder. Timothy E. Wilens, M.D., Oscar Bukstein, M.D., Matthew Brams, M.D., Andrew J. Cutler, M.D., Ann Childress, M.D., Thomas Rugino, M.D., Andrew Lyne, M.Sc., C.Stat., Kara Grannis, B.A., Sharon Youcha, M.D. Visit the Journal of the Academy of Child & Adolescent Psychiatry website to learn more.

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder - Research article by Arif Khan, MD; Andrew J. Cutler, MD; Daniel K. Kajdasz, PhD; Susan Gallipoli, RN; Maria Athanasiou, PhD; Donald S. Robinson, MD; Heidi Whalen, MHS; and Carol R. Reed, MD. VIEW RESEARCH PUBLICATION

Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder - Research article by Robert L. Findling, M.D., Ann C. Childress, M.D., Andrew J. Cutler, M.D., Maria Gasior, M.D., Ph.D., Mohamed Hamdani, M.S., M. Celeste Ferreira-Cornwell, Ph.D., Liza Squires, M.D. April 2011. VIEW RESEARCH PUBLICATION

A Failed 6-Week,Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned - Research article by Andrew J. Cutler, founder of Florida Clinical Research Center and Tram Tran-Johnson, Amir Kalali, Mikael Åström, Martin Brecher, Didier Meulie. VIEW RESEARCH PUBLICATION.

Iloperidone: a new option for the treatment of schizophrenia

Drug profile article by Dr. Andrew J. Cutler. www.expert-reviews.com. Expert Rev. Neurother. 9(12), 1727–1741 (2009).

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. J Clin Psychiatry 70:4, April 2009. Copyright 2009 Physicians Postgraduate Press, Inc. By Andrew J. Cutler, M.D.; Stuart A. Montgomery, M.D.; David Feifel, M.D., Ph.D.; Arthur Lazarus, M.D., M.B.A.; Mikael Åström, M.Sc., Ph.L.; and Martin Brecher, M.D., D.M.Sc., M.B.A.

Four-Week Double-Blind Placebo and Ziprasidone Controlled Trial of lloperidone in Patients With Acute Exacerbations of Schizophrenia

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. Journal of Clinical Psychopharmacology, April 2008. Volume 28 - Number 2, Supplement 1. By Andrew J. Cutler, MD, Amir J. Kalali, MD, Peter J. Weiden, MD, Jennifer Hamilton, MS, and Curt D. Wolfgang, PhD.

A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. American Journal of Psychiatry, 2005. 162: 1351-1360. By Joseph R. Calabrese, MD, Paul E. Keck, Jr., MD, Wayne Macfadden, MD, Margaret Minkwitz, PhD. Terence A. Ketter, MD, Richard H. Weisler, MD, Andrew J. Cutler, MD, Robin McCoy, RN, Ellis Wilson, MS, Jamie Mullen, MD, The BOLDER Study Group.

Dosing Atypical Antipsychotics

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums: The International Journal Of Neuropsychiatric Medicine. Volume 13 - Number 5 (Suppl 9). By Andrew Cutler, MD, Sara Ball, MS, and Stephen M. Stahl, MD, PhD.

Extended-Release Carbamamazepine Capsules as Monotheraphy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. J Clin Psychiatry 66:3, March 2005. Copyright 2005 Physicians Postgraduate Press, Inc. By Richard H. Weisler, MD, Paul E. Keck, Jr., MD, Alan C. Swann, MD, Andrew J. Cutler, MD, Terence A. Ketter, MD and Amir H. Kalali, MD, for the SPD417 Study Group.

The Efficacy and Safety of Lower Doses of Aripiprazole for the Treatment of Patients with Acute Exacerbation of Schizophrenia

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums Volume 11 number - 9, 2006. By Andrew J. Cutler, MD, Ronald N. Marcus, MD,  Sterling A. Hardy, MS, Amy O'Donnell, MD, William H. Carson, MD and Robert D. McQuade, PhD.

The Use of Antiepileptic Drugs in Bipoloar Disorders: A Review Based on Evidence From Controlled Trials

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums Volume 11 number - 10, October 2006. By Richard H. Weisler, MD, Andrew J. Cutler, MD, James C. Ballenger, MD, Robert M. Post, MD and Terence A. Ketter, MD.

An Interim Analysis of the Quality of Life, Effectiveness, Safety and Tolerability (QU.E.S.T.) Evaluation of Mixed Amphetamine Salts Extended Release in Adults With ADHD

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums - December 2005. Volume 10 - Number 12 (suppl 20). By David W. Goodman, MD, Lawrence Ginsber, MD, Richard H. Weisler, MD, Andrew J. Cutler, MD, and Paul Hodgkins, PhD, PMP, RAC.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. Journal of Affective Disorders 112 - 2009. By P.E. Keck a,⁎, P.J. Orsulak b,c, A.J. Cutler d, R. Sancheze, A. Torbeyns f, R.N. Marcusg, R.D. McQuadee, W.H. Carsone The CN138-135 Study Group 1.